Sulzer (SUN) H2 2023 earnings summary
Event summary combining transcript, slides, and related documents.
H2 2023 earnings summary
15 Oct, 2026Executive summary
2023 sales grew across all three divisions and regions; EBITA margin reached 11.1%, ROCE 17.7%, and FCF CHF 301.3m, each at a 10-year or longer high.
Strong market momentum and early benefits from Excellence initiatives supported higher profitability and cash generation.
Financial highlights
Sales CHF 3,281.7m; order intake CHF 3,580.3m; EBITA CHF 365.6m; ONCF CHF 373.9m; FCF CHF 301.3m.
2023 vs 2022: sales +13.2%, order intake +13.9%, and EBITA +25.3%, adjusted for currency and acquisition/disposal effects; FCF +46.1%.
EBIT CHF 330m and net income CHF 230m; reported comparisons rose 35.5% and 54.2%, respectively, excluding 2022 one-off impacts of CHF 147m and CHF 134m.
FCF CHF 301m, up 46.1%; 2022 FCF was reduced by CHF 148m in one-off impacts.
Outlook and guidance
2024 guidance: order intake +2% to 5%, sales +6% to 9%, and operational profitability ~12%.
Order intake expected to remain above 2022 levels, with slower development in 2024 compared with exceptionally strong Q1 2023.
2023 order intake and sales exceeded February 2023 guidance and landed within or at the high end of July 2023 guidance; EBITA margin was 11.1% versus July guidance of ~11%.
Guidance carries risk that actual results may differ materially due to known or unknown risks and other factors.
Latest events from Sulzer
- Order intake rose 1.8% YoY; full-year guidance was reaffirmed.SUN
Q3 2026 TU - EBITDA margin rose to 15.5% as Flow and Services grew; 2026 guidance reaffirmed.SUN
H1 2026 - Q1 2026 order intake fell 8.6% year-over-year, but guidance and outlook for 2026 remain positive.SUN
Q1 2026 TU - Record sales, profit, and margins support a higher dividend and positive 2026 outlook.SUN
H2 2025 - Order intake recovers, Services grow double digits, Chemtech hit by delays; guidance reaffirmed.SUN
Q3 2025 TU - Sales, EBITDA, and net income up; Chemtech lagged, outlook and dividend increased.SUN
H1 2025 - Order and sales growth drove higher profitability and upgraded 2024 guidance.SUN
H1 2024 - Targets above-market growth, >17% EBITDA margin, >22% ROCE, driven by innovation and efficiency.SUN
CMD 2024 - Double-digit sales and order growth, higher margins, and strong 2025 outlook driven by backlog.SUN
H2 2024